GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Shanghai Hile Bio-Technology Co Ltd (SHSE:603718) » Definitions » Cyclically Adjusted Revenue per Share

Shanghai Hile Bio-Technology Co (SHSE:603718) Cyclically Adjusted Revenue per Share : ¥0.56 (As of Mar. 2025)


View and export this data going back to 2015. Start your Free Trial

What is Shanghai Hile Bio-Technology Co Cyclically Adjusted Revenue per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Shanghai Hile Bio-Technology Co's adjusted revenue per share for the three months ended in Mar. 2025 was ¥0.113. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is ¥0.56 for the trailing ten years ended in Mar. 2025.

During the past 12 months, Shanghai Hile Bio-Technology Co's average Cyclically Adjusted Revenue Growth Rate was -5.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

As of today (2025-06-02), Shanghai Hile Bio-Technology Co's current stock price is ¥7.16. Shanghai Hile Bio-Technology Co's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2025 was ¥0.56. Shanghai Hile Bio-Technology Co's Cyclically Adjusted PS Ratio of today is 12.79.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Shanghai Hile Bio-Technology Co was 19.64. The lowest was 10.46. And the median was 14.09.


Shanghai Hile Bio-Technology Co Cyclically Adjusted Revenue per Share Historical Data

The historical data trend for Shanghai Hile Bio-Technology Co's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shanghai Hile Bio-Technology Co Cyclically Adjusted Revenue per Share Chart

Shanghai Hile Bio-Technology Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - 0.58 0.56

Shanghai Hile Bio-Technology Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.59 0.57 0.57 0.56 0.56

Competitive Comparison of Shanghai Hile Bio-Technology Co's Cyclically Adjusted Revenue per Share

For the Biotechnology subindustry, Shanghai Hile Bio-Technology Co's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Shanghai Hile Bio-Technology Co's Cyclically Adjusted PS Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Shanghai Hile Bio-Technology Co's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Shanghai Hile Bio-Technology Co's Cyclically Adjusted PS Ratio falls into.


;
;

Shanghai Hile Bio-Technology Co Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Shanghai Hile Bio-Technology Co's adjusted Revenue per Share data for the three months ended in Mar. 2025 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=0.113/115.1156*115.1156
=0.113

Current CPI (Mar. 2025) = 115.1156.

Shanghai Hile Bio-Technology Co Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201506 0.362 99.500 0.419
201509 0.325 100.500 0.372
201512 0.143 100.600 0.164
201603 0.272 102.200 0.306
201606 0.200 101.400 0.227
201609 0.139 102.400 0.156
201612 0.136 102.600 0.153
201703 0.117 103.200 0.131
201706 0.102 103.100 0.114
201709 0.153 104.100 0.169
201712 0.110 104.500 0.121
201803 0.090 105.300 0.098
201806 0.077 104.900 0.084
201809 0.136 106.600 0.147
201812 0.083 106.500 0.090
201903 0.126 107.700 0.135
201906 0.090 107.700 0.096
201909 0.121 109.800 0.127
201912 0.101 111.200 0.105
202003 0.088 112.300 0.090
202006 0.097 110.400 0.101
202009 0.119 111.700 0.123
202012 0.071 111.500 0.073
202103 0.157 112.662 0.160
202106 0.104 111.769 0.107
202109 0.154 112.215 0.158
202112 0.119 113.108 0.121
202203 0.132 114.335 0.133
202206 0.133 114.558 0.134
202209 0.157 115.339 0.157
202212 0.043 115.116 0.043
202303 0.100 115.116 0.100
202306 0.083 114.558 0.083
202309 0.118 115.339 0.118
202312 0.073 114.781 0.073
202403 0.189 115.227 0.189
202406 0.041 114.781 0.041
202409 0.102 115.785 0.101
202412 0.147 114.893 0.147
202503 0.113 115.116 0.113

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.


Shanghai Hile Bio-Technology Co  (SHSE:603718) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Shanghai Hile Bio-Technology Co's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=7.16/0.56
=12.79

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Shanghai Hile Bio-Technology Co was 19.64. The lowest was 10.46. And the median was 14.09.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Shanghai Hile Bio-Technology Co Cyclically Adjusted Revenue per Share Related Terms

Thank you for viewing the detailed overview of Shanghai Hile Bio-Technology Co's Cyclically Adjusted Revenue per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Shanghai Hile Bio-Technology Co Business Description

Traded in Other Exchanges
N/A
Address
Shanghai Jinhai Road 6720, Shanghai, CHN, 201403
Shanghai Hile Bio-Technology Co Ltd is a veterinary biological product manufacturer integrating research and development, production, sales, and service. The company has over 40 categories of poultry, livestock, and pets. The company provides services for the prevention of livestock diseases, improving the health of livestock and poultry, and improving the production efficiency of farmers, and is able to provide comprehensive solutions and an authoritative veterinary expert service system.
Executives
Zhang Lu Director
Liu Han Ping Directors, senior managers
Zhou Yu Sheng Supervisors
Zhang Hai Ming Director
Sun Guo Bao Supervisors
Zhang Yue Director
Su Bin Director
Wu Ling Yue senior management

Shanghai Hile Bio-Technology Co Headlines

No Headlines